Canada-based cannabis company Cannara Biotech (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF) has raised $2,160,000 through non-brokered private placement of common shares at $0.18 apiece. The net proceeds from will be used for general corporate purposes including the ongoing build-out at the company’s facility and to provide additional working capital.
Cannabis One Holdings (CSE: CBIS) (OTCMKTS:CAAOF) has signed a share purchase agreement to acquire all of the issued and outstanding securities of Green Lady IP, which provides infrastructure services to three dispensaries operated by Green Lady and Green Lady Westside. Two dispensaries are located in Olympia, Wash., and one in Lynnwood, Wash.
Lifestyle Delivery Systems (CSE: LDS) (OTCQX: LDSYF) and TransCanna Holdings (CSE: TCAN) (XETR: TH8) have agreed to terminate the non-binding letter of intent whereby LDS and TransCanna would combine in an amalgamation transaction. After receipt from TransCanna of a request to modify the terms of the amalgamation, the company’s management determined that the proposed transaction would not be in the best interests of its shareholders and, as a result, the LOI has been terminated by mutual agreement.
48North Cannabis (TSXV: NRTH) reported that it has completed the planting of its first outdoor cannabis crop at its Good:Farm, the largest outdoor organic cannabis cultivation facility in Canada, located in Brant County, Ontario.
Vapen MJ Ventures (OTCQX: VAPNF) (CSE: VAPN) announced the quotation of its common shares for trading on the OTCQX Best Market under the symbol “VAPNF”. The company’s MJ’s trading on the OTCQX Market comes as a result of an application and due diligence process including meeting certain financial metrics.
Ontario, Canada-based Tetra Bio-Pharma (TSXV: TBP) (OTCQB: TBPMF), a clinical-stage biopharmaceutical corporation with its primary focus in cannabinoid‑based drug discovery and development, has closed its short form prospectus offering of units, including the exercise in full of the agents’ over-allotment option. A total of 26,833,332 units were sold at a price of $0.30 per unit, for gross proceeds of approximately $8.05 million.
Khiron Life Sciences (TSXV: KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC) issued a corporate update on core commercial and operational activities. The update includes a synopsis of the company’s position related to commercial revenue generating activities as well as an operational update on the status of the cultivation, extraction and testing facilities.
1933 Industries (CSE: TGIF) (OTCQX: TGIFF), a cannabis consumer packaged goods company that owns licensed cultivation and manufacturing assets to support its brands, issued a report on its expanded cannabis extraction capabilities and provided an update regarding its hemp extraction facility. The company has commenced plans to use its original cultivation facility to increase its extraction capacity for concentrates.
Accela, which provides cloud-based solutions for government, is forming a partnership with KIND Financial. Accela says that the KIND’s seed-to-sale platform will be offered to Accela customers to streamline the complex process of tracking the cannabis supply chain for any medical or recreational regulatory environment.
